This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Ly Luu Pham
Introduction
Ly Luu Pham is a notable inventor based in Arlington, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating proliferative diseases such as cancer. With a total of 2 patents to her name, her work continues to impact the medical community.
Latest Patents
Pham's latest patents include a compound known as (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof. This invention is directed towards the treatment of proliferative diseases, including cancer, in mammals. Another significant patent is related to SMAC peptidometics, which are useful as IAP inhibitors, also aimed at treating similar diseases.
Career Highlights
Ly Luu Pham is currently employed at Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative solutions in the pharmaceutical industry, contributing to advancements in cancer treatment.
Collaborations
Throughout her career, Pham has collaborated with esteemed colleagues, including Zhuoliang Chen and Mark G Charest. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Ly Luu Pham's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her role as a significant inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.